JP2020019739A - ナチュラルキラー細胞活性化剤 - Google Patents
ナチュラルキラー細胞活性化剤 Download PDFInfo
- Publication number
- JP2020019739A JP2020019739A JP2018144106A JP2018144106A JP2020019739A JP 2020019739 A JP2020019739 A JP 2020019739A JP 2018144106 A JP2018144106 A JP 2018144106A JP 2018144106 A JP2018144106 A JP 2018144106A JP 2020019739 A JP2020019739 A JP 2020019739A
- Authority
- JP
- Japan
- Prior art keywords
- natural killer
- killer cell
- cell activator
- colloid
- platinum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
[1]白金コロイドとパラジウムコロイドとを含有する、ナチュラルキラー細胞活性化剤。
[2]白金コロイドの濃度が0.08〜16mMの液剤である、[1]に記載のナチュラルキラー細胞活性化剤。
[3]パラジウムコロイドに対する白金コロイドのモル比が、1/30〜10/1であり、[1]又は[2]に記載のナチュラルキラー細胞活性化剤。
[4]パラジウムコロイドの濃度が0.1〜30mMの液剤である、[1]〜[3]のいずれかに記載のナチュラルキラー細胞活性化剤。
[5]固形癌又はウィルス感染症の予防剤、治療剤又は再発予防剤である、[1]〜[4]のいずれかに記載のナチュラルキラー細胞活性化剤。
[6]免疫賦活作用を高める、[1]〜[5]のいずれかに記載のナチュラルキラー細胞活性化剤。
Claims (6)
- 白金コロイドとパラジウムコロイドとを含有する、ナチュラルキラー細胞活性化剤。
- 白金コロイドの濃度が0.08〜16mMの液剤である、請求項1に記載のナチュラルキラー細胞活性化剤。
- パラジウムコロイドに対する白金コロイドのモル比が、1/30〜10/1であり、請求項1又は2に記載のナチュラルキラー細胞活性化剤。
- パラジウムコロイドの濃度が0.1〜30mMの液剤である、請求項1〜3のいずれか1項に記載のナチュラルキラー細胞活性化剤。
- 固形癌又はウィルス感染症の予防剤、治療剤又は再発予防剤である、請求項1〜4のいずれか1項に記載のナチュラルキラー細胞活性化剤。
- 免疫賦活作用を高める、請求項1〜5のいずれか1項に記載のナチュラルキラー細胞活性化剤。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2018144106A JP6635319B1 (ja) | 2018-07-31 | 2018-07-31 | ナチュラルキラー細胞活性化剤 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2018144106A JP6635319B1 (ja) | 2018-07-31 | 2018-07-31 | ナチュラルキラー細胞活性化剤 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP6635319B1 JP6635319B1 (ja) | 2020-01-22 |
JP2020019739A true JP2020019739A (ja) | 2020-02-06 |
Family
ID=69166747
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2018144106A Active JP6635319B1 (ja) | 2018-07-31 | 2018-07-31 | ナチュラルキラー細胞活性化剤 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6635319B1 (ja) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP7039083B1 (ja) * | 2021-07-29 | 2022-03-22 | 株式会社東洋厚生製薬所 | Ampk活性化剤 |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH08511236A (ja) * | 1993-03-18 | 1996-11-26 | シティミューン サイエンシーズ,インコーポレイテッド | 生物学的に活性な因子の毒性を低減させる組成物および方法 |
JPH1160493A (ja) * | 1997-08-18 | 1999-03-02 | Eiichi Tsukiji | 活性酸素を起因とする疾患の治療および予防薬又はその原料 |
JPH11240839A (ja) * | 1998-02-23 | 1999-09-07 | Otsuka Yakuhin Kogyo Kk | 白金とパラジウムのコロイドを主原料とした固形剤の製造方法並びに使用方法 |
JP2001010954A (ja) * | 1999-06-29 | 2001-01-16 | Otsuka Sangyo Kk | 酸化的ストレスに対する保護剤 |
WO2004073723A1 (ja) * | 2003-02-20 | 2004-09-02 | She Tec Co., Ltd. | 貴金属微粒子を含む医薬 |
JP2005126384A (ja) * | 2003-10-24 | 2005-05-19 | Mizu Kk | 薬理機能水、およびその用途 |
JP2006282654A (ja) * | 2005-03-09 | 2006-10-19 | Yakult Honsha Co Ltd | 抗酸化剤 |
US20150017721A1 (en) * | 2013-07-10 | 2015-01-15 | Miltenyi Biotec Gmbh | Method for inducing proliferation of natural killer cells by mobile nanomatrices |
JP6343851B1 (ja) * | 2017-07-28 | 2018-06-20 | 株式会社東洋厚生製薬所 | 抗ピロリ菌剤 |
-
2018
- 2018-07-31 JP JP2018144106A patent/JP6635319B1/ja active Active
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH08511236A (ja) * | 1993-03-18 | 1996-11-26 | シティミューン サイエンシーズ,インコーポレイテッド | 生物学的に活性な因子の毒性を低減させる組成物および方法 |
JPH1160493A (ja) * | 1997-08-18 | 1999-03-02 | Eiichi Tsukiji | 活性酸素を起因とする疾患の治療および予防薬又はその原料 |
JPH11240839A (ja) * | 1998-02-23 | 1999-09-07 | Otsuka Yakuhin Kogyo Kk | 白金とパラジウムのコロイドを主原料とした固形剤の製造方法並びに使用方法 |
JP2001010954A (ja) * | 1999-06-29 | 2001-01-16 | Otsuka Sangyo Kk | 酸化的ストレスに対する保護剤 |
WO2004073723A1 (ja) * | 2003-02-20 | 2004-09-02 | She Tec Co., Ltd. | 貴金属微粒子を含む医薬 |
JP2005126384A (ja) * | 2003-10-24 | 2005-05-19 | Mizu Kk | 薬理機能水、およびその用途 |
JP2006282654A (ja) * | 2005-03-09 | 2006-10-19 | Yakult Honsha Co Ltd | 抗酸化剤 |
US20150017721A1 (en) * | 2013-07-10 | 2015-01-15 | Miltenyi Biotec Gmbh | Method for inducing proliferation of natural killer cells by mobile nanomatrices |
JP6343851B1 (ja) * | 2017-07-28 | 2018-06-20 | 株式会社東洋厚生製薬所 | 抗ピロリ菌剤 |
Non-Patent Citations (2)
Title |
---|
MOLECULAR IMMUNOLOGY, vol. 91, JPN6018040013, 9 September 2017 (2017-09-09), pages 123 - 133, ISSN: 0003940388 * |
川上智史ほか: "白金パラジウムによるヒト胃がん・大腸がん細胞増殖抑制効果に関する検討", 第19回日本統合医療学会 プログラム・抄録集, JPN6017044233, 27 November 2015 (2015-11-27), pages 130, ISSN: 0003940387 * |
Also Published As
Publication number | Publication date |
---|---|
JP6635319B1 (ja) | 2020-01-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kim | Folic acid fortification and supplementation—good for some but not so good for others | |
ES2392443T3 (es) | Uso de una solución acuosa que contiene coloide de platino para el tratamiento de síntomas psiquiátricos | |
Souza et al. | Zinc, vitamin D and vitamin C: perspectives for COVID-19 with a focus on physical tissue barrier integrity | |
Broome et al. | An increase in selenium intake improves immune function and poliovirus handling in adults with marginal selenium status | |
Hirose et al. | The influence of active hexose correlated compound (AHCC) on cisplatin-evoked chemotherapeutic and side effects in tumor-bearing mice | |
JP4772243B2 (ja) | テストステロン濃度を増強するためのマカおよび枝角 | |
JP2019214556A (ja) | 酸化ストレスに起因する疾患の予防又は治療剤 | |
JP6635319B1 (ja) | ナチュラルキラー細胞活性化剤 | |
Tytgat et al. | Clinical and laboratory studies of the antacid and raft‐forming properties of Rennie alginate suspension | |
CN107635554A (zh) | 用于正经受放疗和/或化疗的肿瘤患者的粘膜炎治疗的包含氨基酸的组合物 | |
JP2020117486A (ja) | 難聴の予防又は治療剤 | |
JP6088151B2 (ja) | 医薬組成物 | |
JP2006282654A (ja) | 抗酸化剤 | |
Ren et al. | Intestinal toxicity of metal nanoparticles: silver nanoparticles disorder the intestinal immune microenvironment | |
Yu et al. | Cuproptotic nanoinducer-driven proteotoxic stress potentiates cancer immunotherapy by activating the mtDNA–cGAS–STING signaling | |
JP6343851B1 (ja) | 抗ピロリ菌剤 | |
JP2020117484A (ja) | 脊髄損傷後の障害もしくは症状の予防又は治療剤 | |
JP2020117480A (ja) | 記憶障害の予防又は治療剤 | |
JP2020117483A (ja) | 内臓不快感の予防又は治療剤 | |
JP7039083B1 (ja) | Ampk活性化剤 | |
WO2021262749A1 (en) | Compositions and methods for preventing and/or treating viral infection | |
EP2722053B1 (en) | Antibacterial agent for treating infectious diseases of bacterial origin | |
CN110664830A (zh) | Nadh及其盐在制备防治咽炎的药物或保健品中的应用 | |
WO2021033590A1 (ja) | 屁及び/又は大便の悪臭の低減剤 | |
Hanck | Ascorbic acid and cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A871 | Explanation of circumstances concerning accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A871 Effective date: 20180822 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20180817 |
|
A975 | Report on accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A971005 Effective date: 20181001 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20181016 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20181203 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20181218 |
|
C60 | Trial request (containing other claim documents, opposition documents) |
Free format text: JAPANESE INTERMEDIATE CODE: C60 Effective date: 20190305 |
|
C116 | Written invitation by the chief administrative judge to file amendments |
Free format text: JAPANESE INTERMEDIATE CODE: C116 Effective date: 20190319 |
|
C22 | Notice of designation (change) of administrative judge |
Free format text: JAPANESE INTERMEDIATE CODE: C22 Effective date: 20190319 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20190311 |
|
C22 | Notice of designation (change) of administrative judge |
Free format text: JAPANESE INTERMEDIATE CODE: C22 Effective date: 20190416 |
|
C22 | Notice of designation (change) of administrative judge |
Free format text: JAPANESE INTERMEDIATE CODE: C22 Effective date: 20190917 |
|
C27C | Written answer of applicant after an oral proceeding |
Free format text: JAPANESE INTERMEDIATE CODE: C2721 Effective date: 20190917 |
|
C876 | Explanation why request for accelerated appeal examination is justified |
Free format text: JAPANESE INTERMEDIATE CODE: C876 Effective date: 20190926 |
|
C305 | Report on accelerated appeal examination |
Free format text: JAPANESE INTERMEDIATE CODE: C305 Effective date: 20191018 |
|
C23 | Notice of termination of proceedings |
Free format text: JAPANESE INTERMEDIATE CODE: C23 Effective date: 20191023 |
|
C03 | Trial/appeal decision taken |
Free format text: JAPANESE INTERMEDIATE CODE: C03 Effective date: 20191119 |
|
C30A | Notification sent |
Free format text: JAPANESE INTERMEDIATE CODE: C3012 Effective date: 20191119 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20191121 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20191204 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6635319 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |